Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Get Free Report) has earned a consensus rating of “Hold” from the twenty-two ...

Zimmer Biomet is strategically expanding its global presence to address the huge demand in the musculoskeletal space.

In a report released today, Richard Newitter from Truist Financial maintained a Hold rating on Zimmer Biomet Holdings (ZBH – Research Report). The company’s shares closed yesterday at $104.03. Easily ...

Avantax Advisory Services Inc. lifted its holdings in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Free Report) by 36.7% in the fourth quarter, according to its most recent 13F filing with the ...

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products ...

Zimmer Biomet's ZBH fourth-quarter 2025 performance was driven by its market expansion efforts. The company’s robust Knee business looks promising for growth. Meanwhile, a dull macroeconomic ...

Zimmer Biomet Holdings, Inc. (ZBH) is a leading global medical device company specializing in orthopedic solutions. With a ...

Over the past three months, shares of ZBH have gained 0.7% compared with the industry’s 4.6% growth. With the company consistently focusing on strategic market expansion and new product launches ...